Skip to main content

Pharma News

Pharma Courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Suven Life Sciences Ltd (Suven) announces that the grant of one (1) product patent from China (CN103380131), one (1) product patent from Eurasia (9 Countries) (22043) and one (1) product patent from Hong Kong (HK 1180955)) corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2032.

  • Government included more 88 drugs, surgical and consumables in Jan Aushadhi Scheme to make more covers over different portfolios. Till now Jan Aushadhi stores includes total 488 medicines including - Anti-allergy, Anti-infective, Anti-cancer, Antidiabetic agents, Central Nervous System disease, Cardio Vascular Agents, Eye Nose throat product, Eye disease, Gastro Intestinal Tract disease, Harmone, Non Opoidal Anti Inflammatory Drugs, Non-Steroidal Anti Inflammatory Drugs, Nutrient, Respiratory disease, Skin disease, Vaccine, Vitamins & Minerals, Miscellaneous etc.

  • Offering a potential new approach to preventing deadly heart attacks and strokes, Indian-origin researchers have designed a synthetic nanoparticle that can simultaneously light up invisible plaque build up inside the arteries and also treat it.

  • Amgen announced that the U.S. Food and Drug Administration (FDA) has accepted for review Amgen's supplemental Biologics License Application (sBLA) for the expanded use of Enbrel® (etanercept) to treat pediatric patients with chronic severe plaque psoriasis.

  • Opening for Senior Scientific Officer at University of East London

    UEL’s ambition is to become London’s leading university for civic engagement. We are a vibrant and diverse university located in the heart of east London. Our new corporate plan sets an ambitious agenda for our future success and growth which focuses on the delivery of high quality teaching and learning, and excellence in research.

Subscribe to Pharma News